Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease - An epidemiological perspective

被引:124
作者
Luchsinger, Jose Alejandro [1 ,2 ,3 ,4 ]
机构
[1] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA
[2] Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10027 USA
[3] Columbia Univ Coll Phys & Surg, Dept Med, Div Gen Med, New York, NY 10032 USA
[4] Columbia Univ, Joseph P Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA
基金
美国国家卫生研究院;
关键词
adiposity; overweight; obesity; hyperinsulinemia; insulin; glucose; diabetes; Alzheimer's disease; cognitive impairment;
D O I
10.1016/j.ejphar.2008.02.048
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this manuscript is to provide a comprehensive review of the epidemiologic evidence linking the continuum of adiposity, hyperinsulinemia, and diabetes with Alzheimer's disease. The mechanisms for these associations remain to be elucidated, but may include direct actions from insulin, advanced products of glycosilation, cerebrovascular disease, and products of adipose tissue metabolism. Elevated adiposity in middle age is related to a higher risk of Alzheimer's disease. The evidence relating adiposity in old age to Alzheimer's disease is conflicting. Several studies have shown that hyperinsulinemia, a consequence of higher adiposity and insulin resistance, is also related to a higher risk of Alzheimer's disease. Hyperinsulinemia is a risk factor for diabetes, and numerous studies have shown a relation of diabetes with higher Alzheimer's disease risk. Most studies fail the take into account the continuum linking these risk factors which may result in underestimation of their importance in Alzheimer's disease. The implication of these associations is that a large proportion of the world population may be at increased risk of Alzheimer's disease given the trends for increasing prevalence of overweight, obesity, hyperinsulinemia, and diabetes. However, if proven causal, these associations also present a unique opportunity for prevention and treatment of Alzheimer's disease. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:119 / 129
页数:11
相关论文
共 109 条
[11]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[12]   Diabetes guideline: A summary and comparison of the recommendations of the American Diabetes Association, Veterans Health Administration, and American Association of Clinical Endocrinologists [J].
Clark, MJ ;
Sterrett, JJ ;
Carson, DS .
CLINICAL THERAPEUTICS, 2000, 22 (08) :899-910
[13]   Drug therapy - Alzheimer's disease [J].
Cummings, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (01) :56-67
[14]   Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance [J].
Curb, JD ;
Rodriguez, BL ;
Abbott, RD ;
Petrovitch, H ;
Ross, GW ;
Masaki, KH ;
Foley, D ;
Blanchette, PL ;
Harris, T ;
Chen, R ;
White, LR .
NEUROLOGY, 1999, 52 (05) :971-975
[15]   Pharmacologic therapy for type 2 diabetes mellitus [J].
DeFronzo, RA .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (01) :73-74
[16]   PREVALENCE OF ALZHEIMERS-DISEASE IN A COMMUNITY POPULATION OF OLDER PERSONS - HIGHER THAN PREVIOUSLY REPORTED [J].
EVANS, DA ;
FUNKENSTEIN, H ;
ALBERT, MS ;
SCHERR, PA ;
COOK, NR ;
CHOWN, MJ ;
HEBERT, LE ;
HENNEKENS, CH ;
TAYLOR, JO .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (18) :2551-2556
[17]   Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo [J].
Farris, W ;
Mansourian, S ;
Chang, Y ;
Lindsley, L ;
Eckman, EA ;
Frosch, MP ;
Eckman, CB ;
Tanzi, RE ;
Selkoe, DJ ;
Guénette, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :4162-4167
[18]   Insulin: in search of a syndrome [J].
Ferrannini, E ;
Balkau, B .
DIABETIC MEDICINE, 2002, 19 (09) :724-729
[19]   The natural course of β-cell function in nondiabetic and diabetic individuals -: The insulin resistance atherosclerosis study [J].
Festa, A ;
Williams, K ;
D'Agostino, R ;
Wagenknecht, LE ;
Haffner, SM .
DIABETES, 2006, 55 (04) :1114-1120
[20]   Prevalence and trends in obesity among US adults, 1999-2000 [J].
Flegal, KM ;
Carroll, MD ;
Ogden, CL ;
Johnson, CL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (14) :1723-1727